Compare TLPH & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLPH | UPXI |
|---|---|---|
| Founded | 2005 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 70.3M | 61.8M |
| IPO Year | 2010 | 2021 |
| Metric | TLPH | UPXI |
|---|---|---|
| Price | $1.18 | $1.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 102.2K | ★ 4.8M |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,151,000.00 | ★ $24,998,028.00 |
| Revenue This Year | N/A | $118.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 58.10 |
| 52 Week Low | $0.69 | $0.54 |
| 52 Week High | $1.57 | $7.75 |
| Indicator | TLPH | UPXI |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 62.89 |
| Support Level | $1.17 | $1.24 |
| Resistance Level | $1.29 | $1.28 |
| Average True Range (ATR) | 0.04 | 0.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 27.27 | 73.30 |
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.